Operator Jerrell Shelton Jerrell Shelton having any impact on your business overall, like access the clinical trial sites or anything like that, is that noticeable or not really? Yes, we havenÂ't noticed any impact on that. Yes. So we actually launched that on Monday of this week. So the implementation is ongoing. And so itÂ's been rolling out into our clients and obviously, supporting our activity moving forward. So, one of the biggest – there is a couple of big implementation changes with the V2. So first ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34632 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 88-0313393 (St ...

Cryoport服务市场 - Cryoport服务的市场主要包括生命科学行业，支持生物制药/制药、动物健康和生殖医学市场[7] - 生物制药/制药市场中，细胞和基因疗法已成为生物药物开发的快速增长领域，2022年筹集了超过120亿美元的资金[8] 公司收购情况 - Cryoport在2019年收购了Cryogene Labs，提供温控生物储存解决方案，目前位于德克萨斯州休斯顿[10] - 2020年10月，Cryoport收购了CRYOPDP，提供高价值、时间紧迫和温度敏感的生物制药/制药行业的创新温控物流解决方案[11] - 2020年10月，Cryoport还收购了MVE Biological Solutions，提供生命科学行业的冷冻生物储存和运输系统[13] - Cryoport在2021年4月和5月分别收购了澳大利亚的Critical Transport Solutions Australia和比利时的F-airGate，以增强CRYOPDP在亚太和欧洲地区的温控物流能力[14] - 2022年4月，Cryoport收购了法国的Cell&Co BioServices，进一步增强了其全球温控供应链能力[15] - 2022年7月，Cryoport收购了西班牙的Polar Expres，提供专门针对生命科学行业的温控物流解决方案[16] - 2022年7月，Cryoport还收购了比利时的Cell Matters，提供冷冻生物学专业知识，为细胞疗法提供一致、高质量的起始材料[17] 产品和服务 - Fusion®低温冷冻器是适合偏远地区、孤立实验室、高海拔设施或没有现有液氮基础设施的完美解决方案[21] - MVE生物解决方案的Vario®低温系统支持-20°C至-150°C的温度范围，与传统机械冷冻器相比，功耗仅为1%且整体运营成本节省70%[22] - Cryoport通过技术驱动的供应链解决方案建立了市场领先地位，提供集成平台，为生命科学行业提供保障[23] 公司发展和战略 - 公司从2020年第四季度开始调整报告结构，形成一个可报告的部门，不再按产品和服务、地理区域或监管环境组织[26] - 公司的研发工作重点是不断探索能够改进服务、产品和解决方案功能的新技术[31] 环境、社会和治理（ESG） - 公司于2020年开始进行ESG政策、程序和绩效的内部审查[40] - 公司根据SASB和TCFD的框架和标准公开披露ESG信息[41] - 公司的ESG策略重点关注温室气体排放[43] - 公司使用世界资源研究所的温室气体协议标准计算公司的温室气体排放[44] 公司治理和道德 - 公司致力于诚实、真实和透明的运营，遵守最高的道德和公司治理标准[61] 财务情况 - 公司将多余现金投资于高投资级货币市场基金和投资级短期至中期固定收益证券[171] - 截至2022年12月31日，可转换优先票据的估计公允价值为3.025亿美元[172] - 公司在美国和其他国家运营，面临外汇风险，主要涉及欧元、英镑、人民币和印度卢比等货币[173]

In addition forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to those described in Item 1A Risk Factors and elsewhere in our Annual Report on Form 10-K filed, with the Securities and Exchange Commission and those described from time-to-time in the other reports we file with ...

Cryoport, Inc. (NASDAQ:CYRX) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET Company Participants Todd Fromer - Managing Partner-KCSA Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Dr. Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President, Corporate Development and Investor Relations Conference Call Participants Puneet Souda - SVB Securities John Sourbeer - UBS Brandon Couillard - Jefferies David Larsen - BTIG David Saxon - Needham & Comp ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34632 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 88-0313 ...

Cryoport, Inc. (NASDAQ:CYRX) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Todd Fromer – Managing Partner-KCSA Jerrell Shelton – Chief Executive Officer Tom Heinzen – Vice President, Corporate Development and Investor Relations Robert Stefanovich – Chief Financial Officer Mark Sawicki – Chief Scientific Officer Conference Call Participants John Sourbeer – UBS Richard Baldry – Roth Capital Yuan Zhi – B. Riley Securities David Saxon – Needham & Co. David Larsen – BTIG Jacob J ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______. Commission File Number: 001-34632 CRYOPORT, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 88-0313393 ( ...

CRYOPORT, INC. (NASDAQ: CYRX) FIRST QUARTER 2022 IN REVIEW May 5, 2022 Important information This document provides a review of Cryoport, Inc.'s recent financial and operational performance and a general business outlook. It is designed to be read by interested parties before the regularly scheduled quarterly conference call, which, for this quarter, is scheduled for 5:00 p.m. ET on Thursday, May 5, 2022. Therefore, the conference call will be in the format of a questions and answers session and will addres ...

Cryoport, Inc. (NASDAQ:CYRX) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Todd Fromer - President, KCSA Strategic Communications Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - CSO Conference Call Participants John Sourbeer - UBS Brandon Couillard - Jefferies Michael Jones - SVB Securities Joseph Conway - Needham & Co. Paul Knight - KeyBanc David Larsen - BTIG Yuan Zhi - B. Riley Securities Jacob Johnson - Stephens Operator Thank you for standing by. This is the ...